tiprankstipranks
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market

Kalaris Therapeutics (KLRS) Cash flow

374 Followers

Kalaris Therapeutics Cash Flow

KLRS's free cash flow for Q4 2025 was $-9.33M. For the 2025 fiscal year, KLRS's free cash flow was decreased by $24.53M and operating cash flow was $-9.32M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -42.98M$ -67.70M$ -14.13M$ -9.78M$ -106.32M
Investing Cash Flow
$ -19.72M$ 95.00M$ 0.00$ 0.00$ 185.98M
Financing Cash Flow
$ 159.61M$ 21.00K$ 14.24M$ 12.78M$ 232.00K
End Cash Position
$ 98.05M$ 118.29M$ 3.17M$ 3.06M$ 201.66M
Free Cash Flow
$ -43.18M$ -67.70M$ -14.13M$ -9.78M$ -106.34M
Currency in USD

Kalaris Therapeutics Cash Flow